Dynamic Patterns of serum metabolites in fulminant hepatic failure pigs

Metabolomics

Volumn 8, Issue 5, 2012, Pages 869-879

  Zhou, Pengcheng ^a   Li, Jianzhou ^a   Shao, Li ^a   Lv, Guoliang ^a   Zhao, Lifu ^a   Huang, Haijun ^a   Zhang, Anye ^a   Pan, Xiaoping ^a   Liu, Wei ^a   Xie, Qing ^a   Chen, Deying ^a   Guo, Yongzheng ^a   Hao, Shaorui ^a   Xu, Wei ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Dynamic Patterns; Fulminant hepatic failure; LDA; Metabolite; UPLC MS

Indexed keywords

ACYLCARNITINE; AROMATIC AMINO ACID; BILE ACID; BILE ACID CONJUGATE; ELAIDIC CARNITINE; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCOURSODEOXYCHOLIC ACID; LINOLEYLCARNITINE; LYSOPHOSPHATIDYLCHOLINE; PALMITOYLCARNITINE; PHENYLALANINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; EXTERNAL VALIDITY; FULMINANT HEPATIC FAILURE; MALE; MASS SPECTROMETRY; MEDICAL ASSESSMENT; NONHUMAN; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; SWINE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION;

SUIDAE;

EID: 84867204717     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0381-5     Document Type: Article

References (28)

1. Antoniades, C. G., Berry, P. A., Wendon, J. A., & Vergani, D. (2008). The importance of immune dysfunction in determining outcome in acute liver failure. Journal of Hepatology, 49, 845-861.
2. Benz, C., Angermuller, S., Tox, U., et al. (1998). Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. Journal of Hepatology, 28, 99-106.
3. Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010). Acute liver failure. Lancet, 376, 190-201.
4. Churchwell, M. I., Twaddle, N. C., Meeker, L. R., & Doerge, D. R. (2005). Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences, 825, 134-143.
5. Douglas, W. R. (1972). Of pigs and men and research: a review of applications and analogies of the pig, sus scrofa, in human medical research. Space Life Sciences, 3, 226-234.
6. Feng, B., Wu, S., Lv, S., et al. (2007). Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. Journal of Proteome Research, 6, 2161-2167.
7. Feng, B., Wu, S., Lv, S., et al. (2008). Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transplantation, 14, 1620-1631.
8. Gao, Y. Y., Han, T., & Kan, Z. C. (2009). Clinical study of survival time for chronic liver failure. Zhonghua Gan Zang Bing Za Zhi, 17, 131-134.
9. Hao, S., Xin, J., Lian, J., & Li, L. (2011). Establishing a metabolomic model for the prognosis of hepatitis B virus-induced acute-on-chronic liver failure treated with different liver support systems. Metablomics, 7, 400-412.
10. Hofmann, A. F., Korman, M. G., & Krugman, S. (1974). Sensitivity of serum bile acid assay for detection of liver damage in viral hepatitis type B. Prospective study in five patients. American Journal of Digestive Diseases, 19, 908-910.
11. Li, L. J., Wu, Z. W., Xiao, D. S., & Sheng, J. F. (2004). Changes of gut flora and endotoxin in rats with D-galactosamine-induced acute liver failure. World Journal of Gastroenterology, 10, 2087-2090.
12. Lingens, F. (1968). The biosynthesis of aromatic amino acids and its regulation. Angewandte Chemie (International ed. in English), 7, 350-360.
13. Lv, G., Zhao, L., Zhang, A., et al. (2011). Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs. Biotechnology and Bioengineering, 9, 2229-2236.
14. Malhi, H., Gores, G. J., & Lemasters, J. J. (2006). Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology, 43, S31-S44.
15. Mao, Y., Huang, X., Yu, K., et al. (2008). Metabonomic analysis of hepatitis B virus-induced liver failure: identification of potential diagnostic biomarkers by fuzzy support vector machine. Journal of Zhejiang University-Science B, 9, 474-481.
16. Mutomba, M. C., Yuan, H., Konyavko, M., et al. (2000). Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Letters, 478, 19-25.
17. Nicholson, J. K., & Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455, 1054-1056.
18. Olofsson, K. E., Andersson, L., Nilsson, J., & Bjorkbacka, H. (2008). Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochemical and Biophysical Research Communications, 370, 348-352.
19. Pennington, C. R., Ross, P. E., & Bouchier, I. A. (1977). Serum bile acids in the diagnosis of hepatobiliary disease. Gut, 18, 903-908.
20. Polson, J., & Lee, W. M. (2005). AASLD position paper: the management of acute liver failure. Hepatology, 41, 1179-1197.
21. Radu, C. G., Yang, L. V., Riedinger, M., Au, M., & Witte, O. N. (2004). T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proceedings of the National Academy of Sciences USA, 101, 245-250.
22. Sass, D. A., & Shakil, A. O. (2005). Fulminant hepatic failure. Liver Transplantation, 11, 594-605.
23. Silk, D. B. (1986). Branched chain amino acids in liver disease: Fact or fantasy? Gut, 27(Suppl 1), 103-110.
24. Smith, A. R., Rossi-Fanelli, F., Ziparo, V., et al. (1978). Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Annals of Surgery, 187, 343-350.
25. Want, E. J., Wilson, I. D., Gika, H., et al. (2010). Global metabolic profiling procedures for urine using UPLC-MS. Nature Protocols, 5, 1005-1018.
26. Yang, J., Zhao, X., Liu, X., et al. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research, 5, 554-561.
27. Yu, K., Sheng, G., Sheng, J., et al. (2007). A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. Journal of Proteome Research, 6, 2413-2419.
28. Zhang, L., Jia, X., Peng, X., et al. (2010). Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus. Acta Biochimica et Biophysica Sinica (Shanghai), 42, 688-698.